A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The pivotal phase 3 trial (rAd-IFN-CS 003) evaluating the efficacy of nadofaragene firadenovec showed that 55 (53.4%) of 103 subjects with CIS ± high-grade Ta/T1 achieved a complete response (CR) at 3 months. In this trial, the safety and efficacy of intravesical instillation of nadofaragene firadenovec alone or in combination with chemotherapy or immunotherapy will be evaluated in participants with NMIBC CIS (± high-grade Ta/T1).
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Potwierdzona diagnoza raka pęcherza moczowego w stadium CIS (możliwie ze zmianami Ta/T1 wysokiego stopnia)
- •Brak odpowiedzi na co najmniej 2 serie leczenia BCG w ciągu ostatnich 12 miesięcy
- •Całkowite usunięcie wszystkich widocznych zmian nowotworowych przed badaniem
- •Wiek co najmniej 18 lat
- •Ogólny stan zdrowia pozwalający na uczestnictwo w badaniu (ECOG ≤2)
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 8, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (76)
Center for Neurosciences
Tucson, United States
Arkansas Urology, North Little Rock
Little Rock, United States
American Institute of Research
Los Angeles, United States
USC Kenneth Norris Jr Cancer Hospital
Los Angeles, United States
University of California, Irvine
Orange, United States
Genesis Research, LLC - San Diego
San Diego, United States
Advent Health
Denver, United States
Colorado Urology - St. Anthony Hospital Campus
Lakewood, United States
Yale School of Medicine
New Haven, United States
Medstar Georgetown University Hospital
Washington D.C., United States
Sarasota Memorial Healthcare System
Sarasota, United States
Emory University
Atlanta, United States
Georgia Urology
Atlanta, United States
Boise VA Medical Center
Boise, United States
NextStage Clinical Research
Lisle, United States
Indiana University
Indianapolis, United States
Wichita Urology Group
Wichita, United States
Anne Arundel Urology, PA
Annapolis, United States
Chesapeake Urology Research Associates
Hanover, United States
Atlantic Health
Morristown, United States
Roswell Park Cancer Institute
Buffalo, United States
Great Lakes Physician PC d/b/a Western new York Urology Associates
Cheektowaga, United States
Northwell Health -The Arthur Smith Institute for Urology
Lake Success, United States
Veterans Affairs New York Harbor Healthcare System - Manhattan VA Medical Center
New York, United States
James J. Peters VA Medical Center
The Bronx, United States
University of Cincinnati
Cincinnati, United States
OSU Arthur James Cancer Hospital
Columbus, United States
MidLantic Urology
Bala-Cynwyd, United States
Keystone Urology Specialists
Lancaster, United States
University of Pennsylvania - Perelman Center for Advanced Medicine - Penn Urology
Philadelphia, United States
University of Pittsburgh Medical Center - Shadyside Medical Building
Pittsburgh, United States
Carolina Urologic Research Center
Myrtle Beach, United States
The Conrad Pearson Clinic - Wolf River Office (Urology Center of the South)
Germantown, United States
Urology Associates, P.C.
Nashville, United States
Urology Austin
Austin, United States
Urology Clinics of North Texas PLLC (Dallas)
Dallas, United States
University of Texas Southwestern Medical Center - Urology Clinic
Dallas, United States
Houston Methodist Hospital (Houston)
Houston, United States
Virginia Mason Medical Center
Seattle, United States
Prostate Cancer Centre
Calgary, Canada
University Health Network UHN - Princess Margaret Cancer Centre
Toronto, Canada
Centre Hospitalier de L'Universite de Montreal
Montreal, Canada
Krajska Nemocnice Liberec
Liberec, Czechia
Fakultní Thomayerova Nemocnice
Prague, Czechia
Fakultni nemocnice v Motole
Prague, Czechia
Androgeos, spol. s r.o.
Prague, Czechia
Kromerizska Nemocnice A S
Kroměříž, Czechia
CHU Clermont Ferrand - Hopital Gabriel Montpied
Clermont-Ferrand, France
Hospices Civils de Lyon - Edouard Herriot Hosp.
Lyon, France
CHU Toulouse - Hopital Rangueil
Toulouse, France
CHU Nantes - Hotel Dieu
Nantes, France
CHU de Bordeaux - Hôpital Pellegrin
Bordeaux, France
Centre Hospitalier Universitaire De Nimes (Nîmes)
Nîmes, France
Centre Hospitaliser Universitaire de Lyon Sud
Lyon, France
Hopital La Pitie Salpetriere
Paris, France
APHP - Hopital Bichat
Paris, France
IN-VIVO Bydgoszcz
Bydgoszcz, Poland
Clinical Research Center Spółka z ograniczoną odpowiedzialnością Medic-R Sp.k.
Poznan, Poland
Medical Concierge Centrum Medyczne
Warsaw, Poland
Pusan National University Yangsan Hospital
Yangsan, South Korea
Korea University Anam Hospital
Seoul, South Korea
Samsung Medical Center
Seoul, South Korea
Seoul National University Hospital
Seoul, South Korea
Instituto de Investigacion Valdecilla (IDIVAL) / Hospital universitario Marques de Valdecilla
Santander, Spain
Hospital del Mar
Barcelona, Spain
Hospital Clinic De Barcelona - University of Barcelona
Barcelona, Spain
Hospital Universitario Reina Sofia
Córdoba, Spain
Hospital Universitario de A Coruna
A Coruña, Spain
Hospital Universitario Fundacion Alcorcon
Alcorcón, Spain
Clinica Universidad de Navarra - Madrid
Madrid, Spain
Hospital Universitario 12 De Octubre (Madrid)
Madrid, Spain
Universidad Autonoma de Madrid. Hospital Universitario La Paz
Madrid, Spain
Clinica Universidad de Navarra - Pamplona
Pamplona, Spain
Hospital Universitario Basurto
Bilbao, Spain
MD Anderson Cancer Center
Madrid, Spain
Servicio Andaluz de Salud (SAS) - Hospital Universitario Virgen de la Victoria (HUVV)
Málaga, Spain
Trial contact
Ferring Pharmaceuticals
Ferring Pharmaceuticals
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/9/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.